A new coalition of industry and health charities, led by former Health Minister, raise the alarm over missed opportunities to tackle Antimicrobial Resistance in the UK. Action urgently needed to adopt point of care diagnostics and end years of delay in implementing key recommendations for antimicrobial stewardship.

OGT announces the opening of state-of-the-art facilities within the Oxford Technology Park. The move represents a multi-million-pound investment, fuelled by consistent company growth and growing customer demand. Equipped with cutting-edge technology, the facilities will drive development of OGT’s trusted SureSeq™ next generation sequencing (NGS) product portfolio, as well as deliver expert-led training and enhanced opportunities for collaboration.

BIVDA is pleased to announce the appointment of Professor Mike Messenger as our Head of Regulatory Strategy from 1st March 2024. Professor Mike Messenger is one of the UK’s most respected figures in the regulation of medical and in vitro diagnostics. He is a visiting Professor at the University of Leeds and was formerly Head of Diagnostics at the Medicines and Healthcare products Regulatory Agency (MHRA). During the COVID-19 pandemic, he led development of Target Product Profiles, supported gov...

Paul Fisher, Head of Policy, Programmes and Compliance said: “BIVDA are delighted to see the clear recognition that regulating of products places on manufacturers, and the focus on cross government solutions.  Linking health to innovation and science under one owner is something we have advocated for some time, but we would be keen to see the Department for Business and Trade involved.  Investment and export sales are key to the sector, and the UK’s economic economy.

In an NHS career spanning over 42 years, Angela was most recently the Deputy Chief Scientific Officer for NHS England until retiring from the role in October 2023. Angela brings a unique perspective to the Association, with her experience including; providing scientific oversight to the AMR diagnostics team in the Office of the Chief Scientific Officer, and working alongside NHS Test and Trace in COVID-19 laboratory development, product assay development, technical validation and providing scien...

BIVDA has noted the latest changes in the Prime Minister’s Cabinet and ministerial team. We would like to welcome the new Secretary of State for Health and Social Care, Victoria Atkins.

Fast MDx Ltd, a UK-based molecular diagnostics company who are focussed on the development of medical diagnostics for faster and more accurate diagnosis in healthcare, has announced completion of the ISO 13485:2016 certification.

HORIBA receives accolade for Best New Clinical Instrumentation of 2022 at special ceremony during 2023 AACC.

Glucose-6-phosphate dehydrogenase test kit from HORIBA group company Pointe Scientific, now distributed in UK by HORIBA.

The British In Vitro Diagnostic Association (BIVDA) today announced the appointment of Helen Dent as Interim Chief Executive Officer. Helen will replace outgoing CEO, Doris-Ann Williams, who has retired from her role. Helen will lead the organisation in championing the in vitro diagnostics (IVD) industry to politicians, policymakers, media and relevant stakeholders and in supporting members to improve patient outcomes. Helen, who will step into the role following over three years as Chief Operat...